← Back to Screener
Ginkgo Bioworks Holdings, Inc. (DNA)
Price$7.98
Favorite Metrics
Price vs S&P 500 (26W)-49.35%
Price vs S&P 500 (4W)10.18%
Market Capitalization$492.71M
All Metrics
Book Value / Share (Quarterly)$8.74
P/TBV (Annual)1.11x
Revenue Growth (3Y)-29.11%
Cash Flow / Share (Quarterly)$-3.07
Price vs S&P 500 (YTD)-7.51%
Gross Margin (TTM)72.39%
Net Profit Margin (TTM)-183.81%
EPS (TTM)$-5.64
10-Day Avg Trading Volume1.11M
EPS Excl Extra (TTM)$-5.64
Revenue Growth (5Y)17.28%
EPS (Annual)$-5.64
ROI (Annual)-61.49%
Gross Margin (Annual)72.39%
Net Profit Margin (5Y Avg)-360.73%
Cash / Share (Quarterly)$7.26
Revenue Growth QoQ (YoY)-23.84%
ROA (Last FY)-27.93%
Revenue Growth TTM (YoY)-25.06%
EBITD / Share (TTM)$-4.86
ROE (5Y Avg)-92.41%
Operating Margin (TTM)-194.89%
Cash Flow / Share (Annual)$-3.07
P/B Ratio0.97x
P/B Ratio (Quarterly)0.99x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)1.91x
Net Interest Coverage (TTM)-2640.83x
ROA (TTM)-25.88%
EPS Incl Extra (Annual)$-5.64
Current Ratio (Annual)4.92x
Quick Ratio (Quarterly)4.73x
3-Month Avg Trading Volume1.12M
52-Week Price Return-0.74%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$7.76
P/S Ratio (Annual)2.90x
Asset Turnover (Annual)0.15x
52-Week High$17.58
Operating Margin (5Y Avg)-370.56%
EPS Excl Extra (Annual)$-5.64
CapEx CAGR (5Y)-33.24%
26-Week Price Return-40.61%
Quick Ratio (Annual)4.73x
13-Week Price Return-18.48%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.92x
Enterprise Value$325.504
Revenue / Share Growth (5Y)137.15%
Asset Turnover (TTM)0.14x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)24.29x
Pretax Margin (Annual)-184.30%
Cash / Share (Annual)$7.26
3-Month Return Std Dev112.49%
Gross Margin (5Y Avg)69.44%
Net Income / Employee (TTM)$-1
ROE (Last FY)-61.50%
Net Interest Coverage (Annual)-38.29x
EPS Basic Excl Extra (Annual)$-5.64
Receivables Turnover (TTM)7.29x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-5.64
Receivables Turnover (Annual)7.29x
ROI (TTM)-53.72%
P/S Ratio (TTM)2.90x
Pretax Margin (5Y Avg)-362.08%
Revenue / Share (Annual)$3.07
Tangible BV / Share (Annual)$7.76
Price vs S&P 500 (52W)-35.84%
Year-to-Date Return-3.37%
5-Day Price Return20.21%
EPS Normalized (Annual)$-5.64
ROA (5Y Avg)-58.50%
Net Profit Margin (Annual)-183.81%
Month-to-Date Return31.00%
Cash Flow / Share (TTM)$-0.41
EBITD / Share (Annual)$-4.90
Operating Margin (Annual)-194.89%
ROI (5Y Avg)-92.03%
EPS Basic Excl Extra (TTM)$-5.64
P/TBV (Quarterly)1.11x
P/B Ratio (Annual)0.99x
Inventory Turnover (TTM)24.30x
Pretax Margin (TTM)-184.30%
Book Value / Share (Annual)$8.74
Price vs S&P 500 (13W)-21.34%
Beta1.70x
Revenue / Share (TTM)$2.98
ROE (TTM)-53.72%
52-Week Low$5.37
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.09
2.09
2.09
2.09
Industry Peers — Biological Products(88)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
DNAGinkgo Bioworks Holdings, Inc. | 2.90x | -25.06% | 72.39% | — | $7.98 |
AMGNAmgen Inc | 5.20x | 9.95% | 73.30% | 2.93% | $350.16 |
GILDGilead Sciences Inc | 5.71x | 2.40% | 78.83% | 133.64% | $135.87 |
ARGXargenx SE American Depositary Shares | 12.59x | 89.56% | 150.91% | — | $834.45 |
BNTXBioNTech SE American Depositary Share | 9.06x | -11.81% | 84.21% | — | $105.19 |
BIIBBiogen Inc. Common Stock | 2.72x | 2.22% | 75.69% | -18.77% | $183.34 |
MRNAModerna, Inc. Common Stock | 10.91x | -39.93% | 70.32% | — | $54.59 |
NBIXNeurocrine Biosciences Inc | 4.64x | 21.45% | 98.18% | 2.31% | $131.59 |
EXELExelixis Inc | 4.89x | 6.85% | 96.39% | 31.10% | $43.61 |
TECHBio-Techne Corp. | 7.72x | 1.64% | 66.60% | -20.58% | $60.58 |
IBRXImmunityBio, Inc. Common Stock | 74.42x | 668.31% | 99.34% | — | $8.20 |
About
Ginkgo Bioworks provides a cell programming platform offering biological R&D services and end-to-end solutions across pharmaceuticals, agriculture, food, and industrial markets. The company operates two segments: Cell Engineering, which generates the majority of revenue through customer biological research and development, and Biosecurity, which provides biological threat identification, monitoring, and mitigation services for government and commercial customers.